US Anticoagulation Therapy Market|Key players in the US anticoagulation therapy market are C. H. Boehringer Sohn, Bristol-Myers Squibb , Johnson & Johnson , Pfizer , Daiichi Sankyo and Portola Pharmaceuticals.
The report "US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) - Forecast to 2022", The US anticoagulation therapy market has witnessed a healthy growth rate during the last decade and is expected to grow at a CAGR of 8.5% between 2017 and 2022 to reach USD 27.83 Billion by 2022. Factors such as the rising incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and increasing demand for novel oral anticoagulants (NOACs) is driving the growth of this market.Browse 29 Market Data Tables and 25 Figures spread through 86 Pages and in-depth TOC on "US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) - Forecast to 2022"
http://www.marketsandmarkets.com/Market-Reports/us-anticoagulation-therapy-market-114158575.html?utm_source=OpenPR&utm_medium=Paid
Early buyers will receive 10% customization on reports.
The NOACs segment accounted for the largest share of the US anticoagulation therapy market for drugs in 2016
The US anticoagulation drugs market is categorized into NOACs, warfarin (VKA), and other drugs. In 2016, the NOACs segment accounted for the largest share of the market. Due to the better safety and efficacy of NOACs as compared to traditional therapies, the adoption of NOACs is higher as compared to traditional drugs. In addition, key market players such as Portola Pharmaceuticals (received the FDA approval for its NOAC Betrixaban in July 2017) are focusing on the development of NOACs in order to capitalize on the growth opportunities presented by this shift in market dynamics. Consequently, many other companies are also expected to focus on developing more safe and efficient NOACs in the coming years; this will ensure the continued growth of this segment.
Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownload.asp?id=114158575&utm_source=OpenPR&utm_medium=Paid
The in-office testing devices accounted for the largest share of the US anticoagulation therapy market for PT/INR testing devices in 2016
The global US anticoagulation therapy market for PT/INR testing devices is segmented into in-office testing devices and home testing devices. In 2016, the in-office testing devices segment dominated the US anticoagulation therapy market for PT/INR testing devices. The large share of this segment is mainly attributed to the large number of patients opting for in-office testing services. However, the home testing devices segment is expected to grow at the highest CAGR due to its advantages such as convenience, time & cost savings, and quick result generation. Additionally, the cost of test devices and the tests themselves are often reimbursable.
By type of service, the testing services held the largest market share of the anticoagulation therapy market for clinics in 2016
On the basis of types of services provided, the US anticoagulation therapy market for clinics is categorized into testing services and consulting services. In 2016, the testing services segment accounted for the largest share of the US anticoagulation therapy market for clinics. The recurring need for PT/INR monitoring is the key factor driving the growth of this market. However, the shift of patients toward novel anticoagulant agents and high adoption of home testing devices are expected to restrain the growth of this market to a certain extent
By type of clinics, hospital associated clinics held the largest market share of the anticoagulation therapy market for clinics in 2016
On the basis of type of clinics, the US anticoagulation therapy market for clinics is categorized into hospital associated clinics, independent clinics, and pharmacy-based clinics. In 2016, the hospital associated clinics segment accounted for the largest share of the US anticoagulation therapy market for clinics.
For Further Inquiry: - https://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=114158575&utm_source=OpenPR&utm_medium=Paid
C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the US anticoagulation therapy market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US anticoagulation therapy market for PT/INR home testing devices.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Anticoagulation Therapy Market|Key players in the US anticoagulation therapy market are C. H. Boehringer Sohn, Bristol-Myers Squibb , Johnson & Johnson , Pfizer , Daiichi Sankyo and Portola Pharmaceuticals. here
News-ID: 1741039 • Views: …
More Releases from MarketsandMarkets.com
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players ar …
The report "Concrete Surface Retarders Market by Raw Material (Organic Agents and Inorganic Agents), Type (Water-based and Solvent-based), Application (Residential and Commercial), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", The concrete surface retarders market is projected to grow from USD 72.7 million in 2018 to USD 89.4 million by 2023, at a CAGR of 4.2% between 2018 and 2023. Increase in urban population, demand for…
Precast Concrete Market worth $174.1 billion by 2025 | Major Players are Lafarge …
The report "Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) - Global Forecast to 2025" The global precast concrete market size is projected to grow from USD 130.6 billion in 2020 to USD 174.1 billion by 2025, at a CAGR of 5.9% from 2020 to 2025. The market is projected to grow…
Fire Stopping Materials Market worth $2.4 billion by 2026 : Major Players are Hi …
The report "Fire Stopping Materials Market by Type (Sealants, Mortar, Boards, Putty &Putty Pads, Cast-in Devices), by Application (Electrical, Mechanical, Plumbing), End-Use (Commercial, Industrial & Residential), and Region - Global Forecast to 2026" MarketsandMarkets: The fire stopping materials market is projected to reach USD 2.4 billion by 2026, at a CAGR of 11.6% from USD 1.4 billion in 2021. Fire stopping is a fire protection system for sealings of any…
More Releases for NOAC
Novel Oral AntiCoagulants (NOAC) Market 2022 Global Key Country Analysis | Johns …
The Novel Oral AntiCoagulants (NOAC) Market size is projected to reach the highest Compound Annual Growth Rate (CAGR) during the forecast period. The research study also studies market activities like drivers, new possibilities, insight, and obstacles. It brings into core surveys about market definition, market division, and severe examination on the lookout. The Novel Oral AntiCoagulants (NOAC) Market research report also includes stability, futility, new chances, and risks of the…
Novel Oral AntiCoagulants (NOAC) Market Size 2022: Johnson & Johnson, Bristol-My …
Novel Oral AntiCoagulants (NOAC) Market research report presents the company profile, product specifications, capacity, production value, and 2022-2028 market shares for each company. This market analysis report is generated with the best and most advanced tools of collecting, recording, estimating and analyzing market data. Qualitative and transparent research studies are performed devotedly to offer an excellent industry analysis report for the niche. To figure out the market landscape, brand awareness,…
Novel Oral AntiCoagulants (NOAC) Market 2021 | Detailed Report
The Novel Oral AntiCoagulants (NOAC) market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Novel Oral AntiCoagulants (NOAC) report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The Novel Oral AntiCoagulants (NOAC) research report also provides…
Global Novel Oral AntiCoagulants (NOAC) Market 2020 - Johnson & Johnson , Bristo …
Goble Hematopoietic Stem Cells (HSCs) Market 2020, Market Size Value CAGR (USD Million)and revenue ($$$) for the historical period (2016 – 19) and projected years (2020 – 26), SWOT, Industry, Sales, Demand, Analysis, Opportunities and Forecast to 2026 All Cover in This Report
Hematopoietic Stem Cells (HSCs)
Market study on most trending report Global global Hematopoietic Stem Cells (HSCs) Market 2020 Industry Research Report detailed information on the characterization,…
Novel Oral AntiCoagulants (NOAC) Market to Escalate by Types, Applications, Regi …
This report at InForGrowth studies the global market size of Novel Oral AntiCoagulants (NOAC) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Novel Oral AntiCoagulants (NOAC) in these regions.
This research report categorizes the global Novel Oral AntiCoagulants (NOAC) market by players/brands, region, type and application. This report also studies the global market status, competition…
Novel Oral AntiCoagulants (NOAC) Market 2018 SWOT Analysis by Players: Johnson & …
The Global Novel Oral AntiCoagulants (NOAC) Market 2018 to 2025 renders deep perception of the key regional market status of the Novel Oral AntiCoagulants (NOAC) Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan.
The report on “Global Novel Oral AntiCoagulants (NOAC) Market” is a professional report…